Showing results (1231-1240 of 1,396) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|July 12, 2021
Plasma ctDNA Response Is an Early Marker of Treatment Effect in Advanced NSCLCMichael L Cheng, Christie J Lau, Marina S D Milan, et al.
JCO Precision Oncology|July 12, 2021
Implications of Multigene Panel Testing on Psychosocial Outcomes: A Comparison of Patients With Pancreatic and Breast or Ovarian CancerCathryn Koptiuch, Whitney F Espinel, Wendy K Kohlmann, et al.
JCO Precision Oncology|July 12, 2021
Image-Guided Biopsy for Relapsed Neuroblastoma: Focus on Safety, Adequacy for Genetic Sequencing, and Correlation of Tumor Cell Percent With Quantitative Lesion MIBG UptakeAndrew Samoyedny, Abhay Srinivasan, Lisa States, et al.
JCO Precision Oncology|July 12, 2021
Individualized Molecular Profiling for Allocation to Clinical Trials Singapore Study-An Asian Tertiary Cancer Center ExperienceAmanda O L Seet, Aaron C Tan, Tira J Tan, et al.
JCO Precision Oncology|July 12, 2021
Pilot Study of Dacomitinib for Patients With Metastatic EGFR-Mutant Lung Cancers With Disease Progression After Initial Treatment With OsimertinibNoura J Choudhury, Alex Makhnin, Yosef Y Tobi, et al.
JCO Precision Oncology|October 5, 2020
Identification of Actionable Fusions as an Anti-EGFR Resistance Mechanism Using a Circulating Tumor DNA AssayKatherine Clifton, Thereasa A Rich, Christine Parseghian, et al.
JCO Precision Oncology|October 5, 2020
Development of a DNA Methylation-Based Diagnostic Signature to Distinguish Benign Oncocytoma From Renal Cell CarcinomaKevin Brennan, Thomas J Metzner, Chia-Sui Kao, et al.
JCO Precision Oncology|November 21, 2022
Gene-Level Associations in Patients With and Without Pathogenic Germline Variants in CDKN2A and Pancreatic CancerEsteban Astiazaran-Symonds, Cole Graham, Jung Kim, et al.
JCO Precision Oncology|May 18, 2022
Phase II Study of Lorlatinib in Patients With Anaplastic Lymphoma Kinase-Positive Lung Cancer and CNS-Specific RelapseIbiayi Dagogo-Jack, Geoffrey R Oxnard, Makenzi Evangelist, et al.
JCO Precision Oncology|September 14, 2019
Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working GroupSarah M Nielsen, Diana M Eccles, Iris L Romero, et al.
Pageof 140